Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Cancer Sci. 2012 Nov;103(11):2021-6. doi: 10.1111/j.1349-7006.2012.02407.x. Epub 2012 Sep 14.
Recent studies have shown that some members of the tripartite motif-containing protein (TRIM) family, which is characterized by a conserved RING finger, B-box, and coiled-coil domains, function as important regulators for carcinogenesis. In this study, we tested whether TRIM44 (11p13) acts as a cancer-promoting gene through overexpression in gastric cancer. We analyzed seven gastric cancer cell lines and 112 primary tumors, which were curatively resected in our hospital between 2001 and 2003. Expression of the TRIM44 protein was detected in gastric cancer cell lines (2/7 cell lines; 29%) and primary tumor samples of gastric cancer (29/112 cases; 25%). Knockdown of TRIM44 expression using several specific siRNAs inhibited the proliferation, migration, and invasion of TRIM44-overexpressing cells. Overexpression of the TRIM44 protein was significantly correlated with an advanced type of macroscopic appearance, lymphatic invasion, and higher recurrence rate. TRIM44-overexpressing tumors had a worse overall rate of survival than those with non-expressing tumors (P = 0.0038, log-rank test) in both intensity and proportion expression-dependent manner. TRIM44 positivity was independently associated with worse outcome in multivariate analysis (P = 0.0233, hazard ratio 3.37 [1.18-9.64]). These findings suggest that TRIM44 plays a crucial role in tumor cell proliferation through its overexpression, and highlight its usefulness as a predictor and potential therapeutic target in gastric cancer.
最近的研究表明,三部分基序蛋白(TRIM)家族的某些成员,其特征是保守的 RING 指、B 盒和卷曲螺旋结构域,作为癌发生的重要调节剂。在这项研究中,我们通过在胃癌中过表达来测试 TRIM44(11p13)是否作为致癌基因发挥作用。我们分析了 7 种胃癌细胞系和 112 例在我院 2001 年至 2003 年间根治性切除的原发性肿瘤。在胃癌细胞系(2/7 细胞系;29%)和胃癌原发性肿瘤样本(29/112 例;25%)中检测到 TRIM44 蛋白的表达。使用几种特异性 siRNA 敲低 TRIM44 表达抑制了 TRIM44 过表达细胞的增殖、迁移和侵袭。TRIM44 蛋白的过表达与进展型大体外观、淋巴浸润和更高的复发率显著相关。在强度和比例表达依赖性方式下,TRIM44 过表达肿瘤的总生存率明显低于无表达肿瘤(P=0.0038,对数秩检验)。在多变量分析中,TRIM44 阳性与较差的预后独立相关(P=0.0233,风险比 3.37[1.18-9.64])。这些发现表明,TRIM44 通过其过表达在肿瘤细胞增殖中起关键作用,并突出其作为胃癌预测因子和潜在治疗靶点的有用性。